23 July 2013
Russia’s pharma-industry is on the cusp of a golden era, states a recent report from PwC on the sector called “Pharma 2020: From Vision to Decision”. Major scientific and technological advances, alongside socio-demographic changes and increasing demand for medicines, will revive pharma’s fortunes post 2020, PwC’s experts claim.
What are the reasons behind this optimism? What is the current state of this industry in Russia? Are foreign investors going to participate in this growth story? And what is the government’s vision of the situation? We’ll try and answer those questions today on Russia Business Report.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024